Figure 5.
Cyclin D1 induces miR-17-5p and miR-20a expression. (A) Northern blotting showed the increased expression of miR-17-5p and miR-20a in the MSCV–cyclin D1–infected MEF cells. miR-100 was used as a negative control. tRNA served as loading control. (B) Breast cancer cell line MCF-7. (C) cyclin D1−/−, and cyclin D1+/+ MEFs were starved by 5% charcoal-stripped serum for 48 h, followed by 10% FBS stimulation. The time course examination of the cyclin D1 protein level and the miR-17-5p expression level were performed by Western and Northern blots, respectively. The results showed the induction of cyclin D1 and miR-17-5p by serum stimulation in the MCF-7 and cyclin D1+/+ MEF cells, but not in cyclin D1−/− MEFs. (D) miR-17-5p and miR-20a detection in the MMTV–cyclin D1 transgene induced mammary tumors (n = 3) compared with normal mice mammary gland. Data from three mammary tumor samples were presented as mean ± SEM. (E) Real-time PCR analysis of cyclin D1 chromatin immunoprecipitated DNA. 11 fragments derived from chromosome 11q31 upstream of miR-17/20 cluster were examined. For each fragment, amplifications on chromatin before immunoprecipitation and chromatin immunoprecipitated with preimmune serum were performed as input and negative control, respectively. This experiment was repeated three times; data are equal to mean ± SEM.